HR 5616
115th Congress
House
Health
Alternative treatments
Congressional oversight
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Government studies and investigations
Health care coverage and access
Health programs administration and funding
Medicaid
Medical research
Medicare
Minority health
Prescription drugs
Opioid Minority Health Report to Congress Act of 2018
Introduced: April 25, 2018
Introduced by:
Clarke, Yvette D.
Democratic
· New York
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 3, 2018
Referred to the Subcommittee on Health.
Apr 25, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 25, 2018
Introduced in House
Plain-English summary
Opioid Minority Health Report to Congress Act of 2018
This bill requires the National Institute of Minority Health and Health Disparities to report annually on the impact of the opioid epidemic on racial and ethnic minority groups, including the scope of the epidemic, whether expansion of coverage for medication-assisted treatment under the Medicare and Medicaid programs could decrease opioid use and overdose deaths, and the extent of participation by such groups in pain management clinical trials.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3
Cosponsors
1